Skip to main content

Want a detailed portfolio tracker?

Acurx Pharmaceuticals (ACXP) P/E (2021 - 2026)

Acurx Pharmaceuticals (ACXP) P/E from Jun 25, 2021 to Jul 21, 2026. The TTM Acurx Pharmaceuticals (ACXP) P/E is -0.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Acurx Pharmaceuticals (ACXP)

YearP/EChange
2026-0.40-16.10%
2025-0.48-49.28%
2024-0.94-74.67%
2023-3.71+0.42%
2022-3.69+13.87%
2021-3.24N/A

Comparison Acurx Pharmaceuticals (ACXP) P/E with competitors

Acurx Pharmaceuticals (ACXP) P/E is -0.40.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.43%
NBYStablecoin Development Corp0.00-101.08%
ENLVEnlivex Ltd0.07-118.72%
FGENFibroGen Inc0.24-160.07%
CHRSCoherus Biosciences Inc0.85-312.36%
FBIOFortress Biotech Inc0.95-337.51%
ORMPOramed Pharmaceuticals Inc1.50-476.17%
AGENAgenus Inc3.01-853.21%
INVAInnoviva Inc3.15-889.35%
VXRTVaxart Inc3.55-988.38%
CRMDCorMedix Inc3.63-1008.08%
CVACCureVac N.V.4.45-1212.60%
GLPGGalapagos NV4.86-1316.02%
SRPTSarepta Therapeutics Inc4.88-1321.83%
ABEOAbeona Therapeutics Inc5.39-1448.32%
ABUSArbutus Biopharma Corp5.60-1500.40%
ZVRAZevra Therapeutics Inc5.89-1573.38%
SPROSpero Therapeutics Inc6.23-1658.77%
CGENCompugen Ltd6.31-1680.17%
RIGLRigel Pharmaceuticals6.87-1819.85%
SLXNSilexion Therapeutics Corp7.30-1925.97%
OMEROmeros Corporation9.26-2417.16%
AUPHAurinia Pharmaceuticals Inc9.58-2498.80%
PLXProtalix BioTherapeutics Inc10.89-2825.66%
ACADAcadia Pharmaceuticals Inc11.73-3035.27%
TBPHTheravance Biopharma Inc12.26-3168.82%
ADMAAdma Biologics Inc12.42-3207.86%
HRMYHarmony Biosciences Holdings Inc13.82-3558.75%
SABSSAB Biotherapeutics Inc14.14-3637.84%
NAGENiagen Bioscience Inc14.82-3808.50%
INCYIncyte Corp15.82-4059.88%
REGNRegeneron Pharmaceuticals Inc15.86-4068.41%
PBYIPuma Biotechnology Inc17.32-4433.56%
CPRXCatalyst Pharmaceuticals Inc17.44-4464.50%
EXELExelixis Inc17.54-4489.20%
TGTXTG Therapeutics Inc18.97-4846.60%
MDXGMimedx Group Inc20.55-5243.63%
XOMAXOMA Royalty Corp22.87-5824.95%
ARGXArgen X SE24.30-6181.17%
CTMXCytomX Therapeutics Inc24.82-6312.09%
XOMAOXOMA Royalty Corp25.34-6443.16%
HALOHalozyme Therapeutics Inc25.62-6512.96%
XOMAPXOMA Royalty Corp25.67-6524.58%
VRTXVertex Pharmaceuticals Inc27.99-7106.37%
RPRXRoyalty Pharma plc - Class A28.69-7279.76%
SLNOSoleno Therapeutics Inc29.02-7361.80%
ASNDAscendis Pharma A/S30.09-7629.65%
LGNDLigand Pharmaceuticals Inc - Class B37.91-9588.41%
APLSApellis Pharmaceuticals Inc39.02-9866.02%
BMRNBiomarin Pharmaceutical Inc42.21-10664.55%
KRYSKrystal Biotech Inc45.34-11448.32%
ONCBeiGene Ltd69.54-17504.21%
PHARPharming Group N.V.75.03-18877.00%
TECHBio-Techne Corp101.96-25617.60%
VCELVericel Corp109.92-27610.53%
ALNYAlnylam Pharmaceuticals Inc117.96-29623.68%
GMABGenmab140.29-35211.23%
TLXTelix Pharmaceuticals Ltd162.15-40682.75%
CORTCorcept Therapeutics Inc212.86-53372.85%